Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 34, 2004 - Issue 9
45
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Different mechanisms of handling ingested polycyclic aromatic hydrocarbons in mammalian species: organ-specific response patterns of CYP1A1-induction after oral intake of PAH-contaminated soils

, , , &
Pages 781-795 | Received 10 Sep 2004, Published online: 22 Sep 2008

References

  • ARLOTTO, M. P. and PARKINSON, A., 1989, Identification of cytochrome P450a (P450IIA1) as the principal testosterone 7alpha-hydroxylase in rat liver microsomes and its regulation by thyroid hormones. Archives of Biochemistry and Biophysics, 270, 458–471.
  • BADAWI, A. F., CAVALIERI, E. L. and ROGAN, E. G., 2000, Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17beta-estradiol in female Sprague-Dawley rats. Carcinogenesis, 21, 1593–1599.
  • BOUCHARD, M. and VIAU, C., 1997, Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration. Canadian Journal of Physiology and Pharmacology, 75, 185–192.
  • BRAUZE, D., WIELGOSZ, S. M., PAWLAK, A. L. and BAER-DUBOWSKA, W., 1997, Effect of the route of benzo[a]pyrene administration on sister chromatid exchange and DNA binding in bone marrow of mice differing with respect to cytochrome P450 1A1 induction. Toxicology Letters, 91, 211–217.
  • BURKE, M. D., THOMPSON, S., ELCOMBE, C. R., HALPERT, J., HAAPARANTA, T. and MAYER, R. T., 1985, Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology, 34, 3337–3345.
  • CARRIERE, V., GOASDUFF, T., RATANASAVANH, D., MOREL, F., GAUTIER, J. -C., GUILLOUZO, A., BEAUNE, P. and BERTHOU, F., 1993, Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorozoxazone. Chemical Research in Toxicolology, 6, 852–857.
  • CAVALIERI, E. L., STACK, D. E., DEVANESAN, P. D., TODOROVIC, R., DWIVEDY, I., HIGGINBOTHAM, S., JOHANSSON, S. L., PATIL, K. D., GROSS, M. L., GOODEN, J. K., RAMANATHAN, R., CERNY, R. L. and ROGAN, E. G., 1997, Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proceedings of the National Academy of Science USA, 94, 10937–10942.
  • CHENG, Z. N., SHU, Y., Liu, Z. Q., WANG, L. S., OU-YANG, D. S. and ZHOU, H. H., 2001, Role of cytochrome P450 in estradiol metabolism in vitro. Acta Pharmacologica Sinica, 22, 148–154.
  • GALBRAITH, R. A. and MICHNOVICZ, J. J., 1993, Omeprazole fails to alter the cytochrome P450-dependent 2-hydroxylation of estradiol in male volunteers. Pharmacology, 47, 8–12.
  • GUENGERICH, F. P., 1977, Separation and purification of multiple forms of microsomal cytochrome P450. Partial characterization of three apparently homogeneous cytochromes P450 prepared from livers of phenobarbital and 3-methylcholanthrene treated rats. Journal of Biological Chemistry, 252, 3970–3979.
  • GUENGERICH, F. P., 1992, Metabolic activation of carcinogens. Pharmacology CI Therapeutics, 54, 17–61.
  • HACK, A. and SELENKA, F., 1996, Mobilization of PAH and PCB from contaminated soil using a digestive tract model. Toxicology Letters, 88, 199–210.
  • HENGSTLER, J. G., VAN DER BURG, B., STEINBERG, P. and OESCH, F., 1999, Interspecies differences in cancer susceptibility and toxicity. Drug Metabolism Reviews, 31, 917–970.
  • IOANNIDES, C. and PARKE, D. V., 1993, Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metabolism Reviews, 25, 485–501.
  • JELLINCK, P. H., MICHNOVICZ, J. J. and BRADLOW, H. L., 1991, Influence of indole-3-carbinol on the hepatic microsomal formation of catechol estrogens. Steroids, 56, 446–450.
  • Ko, Y., ABEL, J., HARTH, V., BRODE, P., ANTONY, C., DONAT, S., FISCHER. H. P., ORTIZ-PALLARDO, M. E., THIER, R., SACHINIDIS, A., VETTER, H., BOLT, H. M., HERBERHOLD, C. and BRINING, T., 2001, Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Research, 61, 4398–4404.
  • LEE, A. J., KosH, J. W., CONNEY, A. H. and ZFR3, B. T., 2001, Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. Journal of Pharmacology and Experimental Therapeutics, 298, 420–432.
  • LEE, A. J., CAI, M. X., THOMAS, P. E., CONNEY, A. H. and ZHU, B. T., 2003, Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology, 144, 3382–3398.
  • LI, D. N., SEIDEL, A., PRITCHARD, M. P., WOLF, C. R. and FRIEDBERG, T., 2000, Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics,10, 343–353.
  • LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • MCDONNELL, W. M., SCHEIMAN, J. M., TRABER, P. G., 1992, Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract. Gastroenterology, 103, 1509–1516.
  • MCFADYEN, M. C., MCLEOD, H. L., JACKSON, F. C., MELVIN, W. T., DOEHMER, J. and MURRAY, G. I., 2001, Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. Biochemical Pharmacology, 62, 207–212.
  • MURRAY, G. I., TAYLOR, M. C., MCFADYEN, M. C. E, McKAY, J. A., GREENLEE, W. F., BURKE, M. D. and MELVIN, W. T., 1997, Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Research, 57, 3026–3031.
  • MURRAY, G. I., MELVIN, W. T., GREENLEE, W. F. and BURKE, M. D., 2001, Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annual Review of Pharmacology and Toxicology, 41, 297–316.
  • NEBERT, D. W., PUGA, A. and VASILIOU, V., 1993, Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Annals of the New York Academy of Science, 685, 624–640.
  • OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
  • ROOS, P. H., VAN AFFERDEN, M., STROTKAMP, D., PFEIFER, F. and HANSTEIN, W. G., 1996, Liver microsomal levels of CYP1A as biomarker for exposure and for bioavailability of soil-bound polycyclic aromatic hydrocarbons. Archives of Environmental Contamination and Toxicology, 30, 107–113.
  • ROOS, P. H., 2002, Differential induction of CYP1A1 in duodenum, liver and kidney of rats after oral uptake of soils contaminated with polycyclic aromatic hydrocarbons. Archives of Toxicology, 76, 75–82.
  • ROOS, P. H., TSCHIRBS, S., WELGE, P., HACK, A., THEEGARTEN, D., MOGILEVSKI, G. and WILHEL M., 2002, Induction of cytochrome P450 1A1 in multiple organs of minipigs after oral exposure to soils contaminated with polycyclic aromatic hydrocarbons (PAH). Archives of Toxicology, 76, 326–334.
  • SAMUNI, A. M., CHUANG, E. Y., KRISHNA, M. C., STEIN, W., DEORAFF, W., Russo, A. and MITCHELL, J. B., 2003, Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants. Proceedings of the National Academy of Science USA, 100, 5390–5395.
  • SCHENKMAN, J. B., 1992, Steroid metabolism by constitutive cytochromes P450. Journal of Steroid Biochemistry and Molecular Biology, 43, 1023–1030.
  • SEATON, M. J., SCHLOSSER, P. and MEDINSKY, M. A., 1995, In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity. Carcinogenesis, 16, 1519–1527.
  • SHEWEITA, S. A., 2000, Drug-metabolizing enzymes: mechanisms and functions. Current Drug Metabolism, 1, 107–132.
  • SHIMADA, T., HAYES, C. L., YAMAZAKI, H., AMIN, S., HECHT, S. S., OUENGERICH, F. P. and SUTTER, T. R., 1996, Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Research, 56, 2979–2984.
  • SHIMADA, T., ODA, Y., OILLAM, E. M., OUENGERICH, F. P. and INouE, K., 2001, Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metabolism and Disposition, 29, 1176–1182.
  • SHIMADA, T., INouE, K., SUZUKI, Y., KAWAI, T., AZUMA, E., NAKAJIMA, T., SHINDO, M., KUROSE, K., SUGIE, A., YAMAGISHI, Y., FUJII-KURIYAMA, Y. and HASHIMOTO, M., 2002, Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis, 23, 1199–1207.
  • SPINK, D. C., SPINK, B. C., ZHUO, X., HUSSAIN, M. M., OIERTHY, J. F. and DING, X., 2000, NADPH-and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1. Journal of Steroid Biochemistry and Molecular Biology, 74, 11–18.
  • SWINDLE, M. M. and SMITH, A. C., 1998, Comparative anatomy and physiology of the pig. Scandinavian Journal of Laboratory Animal Science, Suppl. 25, 11–22.
  • TAKEMOTO, K., YAMAZAKI, H., TANAKA, Y., NAKAJIMA, M. and YOKOI, T., 2003, Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica, 33, 43–55.
  • THIER, R., BRUNING, T., Roos, P. H. and BOLT, H. M., 2002, Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer? Archives of Toxicology, 76, 249–256.
  • TRABER, P. G., WANG, W. and Yu, L., 1992, Differential regulation of cytochrome P-450 genes along rat intestinal crypt-villus axis. American Journal of Physiology, 263, G215—G223.
  • TSCHIRBS, S., WELGE, P., HACK, A., WILHELM, M. and Roos, P. H., 2004, Differential modulation of the cytochrome P450 system by ingested PAH-contaminated soil in male and female minipigs. Archives of Pharmacology, 369 (Suppl. 1), R105.
  • VAN DE WIEL, J. A., FIJNEMAN, P. H., DUIJF, C. M., ANZION, R. B., THEUWS, J. L. and Bos, R. P., 1993, Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: influence of route of administration, sex and long-term ethanol treatment. Toxicology, 80, 103–115.
  • YAMAZAKI, H., SHAW, P. M., OUENGERICH, F. P. and SHIMADA, T., 1998, Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chemical Research in Toxicology, 11, 659–665.
  • ZHANG, Q. Y., WIKOFF, J., DUNBAR, D., FASCO, M. and KAMINSKY, L., 1997, Regulation of cytochrome P4501A1 expression in rat small intestine. Drug Metabolism and Disposition, 25, 21–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.